芬太尼与吗啡对ST段抬高型心肌梗死患者替格瑞洛诱导的血小板抑制作用的影响：PERSEUS随机试验 - Suppr | 超能文献

相似文献

1

Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.芬太尼与吗啡对ST段抬高型心肌梗死患者替格瑞洛诱导的血小板抑制作用的影响：PERSEUS随机试验

Circulation. 2020 Dec 22;142(25):2479-2481. doi: 10.1161/CIRCULATIONAHA.120.049287. Epub 2020 Dec 21.

2

Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial.静脉注射芬太尼与吗啡对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者替格瑞洛吸收和血小板抑制的影响：PERSEUS 随机试验的原理和设计。

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):158-163. doi: 10.1093/ehjcvp/pvy031.

3

Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial.芬太尼延迟口服替格瑞洛的血小板抑制作用：PACIFY 随机临床试验的完整报告。

Thromb Haemost. 2018 Aug;118(8):1409-1418. doi: 10.1055/s-0038-1666862. Epub 2018 Jul 4.

4

Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.普拉格雷或替卡格雷用于患有糖尿病的ST段抬高型心肌梗死患者

Circulation. 2017 Aug 8;136(6):602-604. doi: 10.1161/CIRCULATIONAHA.117.028745.

5

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中，用坎格瑞洛和替卡格雷洛进行血小板抑制。

Circulation. 2019 Apr 2;139(14):1661-1670. doi: 10.1161/CIRCULATIONAHA.118.038317.

6

Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).静脉注射芬太尼对接受经皮冠状动脉介入治疗患者替格瑞洛吸收及血小板抑制的影响：PACIFY随机临床试验（替格瑞洛抑制血小板聚集与芬太尼）

Circulation. 2018 Jan 16;137(3):307-309. doi: 10.1161/CIRCULATIONAHA.117.031678. Epub 2017 Oct 18.

7

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.心梗后早期应用标准剂量与低维持剂量替格瑞洛的血小板抑制作用（ELECTRA）：一项随机、开放标签、阳性对照的药效学和药代动力学研究。

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):139-148. doi: 10.1093/ehjcvp/pvz004.

8

The MOVEMENT Trial.MOVEMENT 试验。

J Am Heart Assoc. 2019 Jan 22;8(2):e010152. doi: 10.1161/JAHA.118.010152.

9

Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial.比较替格瑞洛诱导的 ST 段抬高型心肌梗死患者血小板抑制作用下，芬太尼与吗啡的效果：PERSEUS 随机试验的完整结果。

Cardiol J. 2022;29(4):591-600. doi: 10.5603/CJ.a2022.0049. Epub 2022 Jun 28.

10

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.替格瑞洛递增负荷剂量方案对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的影响：一项前瞻性随机药代动力学和药效学研究的结果。

JACC Cardiovasc Interv. 2015 Sep;8(11):1457-1467. doi: 10.1016/j.jcin.2015.02.030.

引用本文的文献

1

Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial.芬太尼和吗啡剂量对ST段抬高型心肌梗死患者替格瑞洛诱导的血小板抑制的不同影响：来自PERSEUS随机试验的亚组分析

Front Cardiovasc Med. 2024 Apr 2;11:1324641. doi: 10.3389/fcvm.2024.1324641. eCollection 2024.

2

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.优化合并心血管疾病和胃肠道疾病患者的抗栓治疗

Nat Rev Cardiol. 2024 Aug;21(8):574-592. doi: 10.1038/s41569-024-01003-3. Epub 2024 Mar 20.

3